Paper · 42952650
Serum β-defensin-3 and inflammatory markers for discriminating diabetic foot infection and infection severity: a retrospective study.
Ma Y and 4 others. Front Endocrinol (Lausanne), 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Serum β-defensin-3 and inflammatory markers for discriminating diabetic foot infection and infection severity: a retrospective study. Papers, record 42952650. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42952650
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum β-defensin-3 and inflammatory markers for discriminating diabetic foot infection and infection severity: a retrospective study.
- Journal
- Front Endocrinol (Lausanne)
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-30
Source PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| beta-Defensins | Major topic |
| Diabetic Foot | Major topic |
| Biomarkers | Major topic |
| Inflammation | Major topic |
| Humans | |
| Male | |
| Female | |
| Retrospective Studies | |
| Middle Aged | |
| Severity of Illness Index | |
| Aged | |
| Case-Control Studies | |
| ROC Curve |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References30
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,777,272 | Negative pressure wound therapy (NPWT) is superior to conventional moist dressings in wound bed preparation for diabetic foot ulcers: A randomized controlled trial. | Saudi Med J | 2023 | https://conductscience.org/library/papers/37777272 | PubMed |
| 2 | 37,403,337 | Risk factor analysis for diabetic foot ulcer-related amputation including Controlling Nutritional Status score and neutrophil-to-lymphocyte ratio. | Int Wound J | 2023 | https://conductscience.org/library/papers/37403337 | PubMed |
| 3 | 37,132,611 | Antimicrobial Peptides for Diabetic Wound Healing: Preclinical and Clinical Studies. | Adv Wound Care (New Rochelle) | 2025 | https://conductscience.org/library/papers/37132611 | PubMed |
| 4 | 39,534,259 | The association of the perioperative neutrophil-to-lymphocyte ratio with wound healing in patients with Wagner grade 3 and 4 diabetic foot ulcers after tibial cortex transverse transport surgery: a prospective observational cohort study. | Front Endocrinol (Lausanne) | 2024 | https://conductscience.org/library/papers/39534259 | PubMed |
| 5 | 37,583,519 | Serum Procalcitonin (PCT) - Is there a Role as an Early Biomarker in Infected Diabetic Foot Ulcer (IDFU) Patients? | Malays Orthop J | 2023 | https://conductscience.org/library/papers/37583519 | PubMed |
| 6 | 38,582,501 | Innovative Bio-based Hydrogel Microspheres Micro-Cage for Neutrophil Extracellular Traps Scavenging in Diabetic Wound Healing. | Adv Sci (Weinh) | 2024 | https://conductscience.org/library/papers/38582501 | PubMed |
| 7 | 38,453,058 | Correlational analysis of PLIN1 with inflammation in diabetic foot ulcer wounds. | Diabetes Res Clin Pract | 2024 | https://conductscience.org/library/papers/38453058 | PubMed |
| 8 | 41,358,893 | 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2026. | Diabetes Care | 2026 | https://conductscience.org/library/papers/41358893 | PubMed |
| 9 | 37,779,457 | IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections (IWGDF/IDSA 2023). | Clin Infect Dis | 2023 | https://conductscience.org/library/papers/37779457 | PubMed |
| 10 | 35,092,133 | Antimicrobial peptide derived from insulin-like growth factor-binding protein 5 improves diabetic wound healing. | Wound Repair Regen | 2022 | https://conductscience.org/library/papers/35092133 | PubMed |
1 to 10 of 30
See all 30 referencesCited by0
The papers in our copy of PubMed whose reference list names this one, newest first.
None in this release.
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42952650
GET https://conductscience.org/api/papers/v1/42952650/references?page=2